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Background: Both Wnt5a overexpression and macrophage infiltration have been implicated in inflammation and
cancer. The aim of this study is to reveal the involvement of Wnt5a in macrophage recruitment in gastric cancer.
Methods: mRNA expression in gastric cancer tissues and cells was investigated by real-time PCR. Protein secretion
by gastric cancer cells was determined by ELISA. PcDNA3.1-Wnt5a expression vector and Wnt5a siRNA vector were
used to overexpress and silence Wnt5a expression in gastric cells, respectively. Macrophage migration was analyzed
by transwell, and macrophage cytoskeleton was stained with FITC-phalloidin.
Results: Wnt5a was overexpressed in gastric cancer tissues, and correlated with monocyte chemotactic protein 1
(MCP-1) and interleukin 1β (IL-1β), respectively. In gastric cancer cells, Wnt5a induced MCP-1 expression, which was
mediated by IL-1β. Conditioned medium from gastric cancer cells transfected with Wnt5a stimulated macrophage
chemotaxis and cytoskeletal changes via MCP-1, which were suppressed by recombinant IL-1 receptor antagonist
(rIL-1Ra).
Conclusions: These results suggest that Wnt5a is involved in macrophage recruitment by upregulating MCP-1, and
IL-1Ra may be used to inhibit macrophage recruitment in gastric cancer.Background
Roles of noncanonical Wnt5a in human malignancies
seem to mainly depend on its action on canonical Wnt/
β-catenin pathway. In some conditions, Wnt5a functions
as a tumor suppressor by antagonizing the oncogenic
β-catenin dependent pathway [1-3]. However, in other
conditions, Wnt5a has no effect on β-catenin signaling,
and acts as a tumor promoter due to its stimulatory
action on tumor migration and invasion [4,5]. Actually,
Wnt5a may play more complicated roles in human
tumors. Recent studies have demonstrated that Wnt5a is
implicated in inflammation. Some inflammatory stimuli
were found to trigger the production of Wnt5a, which
subsequently induced the secretion of inflammatory cyto-
kines [6-8]. Acute inflammatory response is favorable for
the eradication of pathogens and tumor cells, whereas
chronic inflammation with persistent existence of inflam-
matory cytokines is closely linked to carcinogenesis [9,10].* Correspondence: zhaochenghai1@sina.com
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unless otherwise stated.Macrophage infiltration is frequently observed in tumor
tissues, which plays a dual role in tumor initiation and
progression. Activated macrophages can directly remove
tumor cells, or destroy tumor cells via secreted mediators,
such as cytokines and nitric oxide. However, long-standing
macrophages may undergo phenotype changes, and pro-
duce tumor-promoting cytokines, chemokines and growth
factors [11]. Macrophage recruitment in tumor micro-
environment is usually attributed to some chemokines
which are produced by both tumor cells and stromal
cells. In gastric inflammation and cancer, macrophage
infiltration is associated with the overproduction of
monocyte chemotactic protein 1 (MCP-1) [12,13].
Induction of MCP-1 is related to some inflammatory
cytokines, such as interleukin 1β (IL-1β) and tumor
necrosis factor α (TNF-α) [14-17]. These cytokines are
overproduced in gastric inflammation and cancer,however,
it remains unknown whether these cytokines regulate
MCP-1 expression in gastric epithelial cells. Furthermore,
it is not clear whether Wnt5a stimulates the production of
these cytokines. In the present study, we investigated the
effect of Wnt5a on MCP-1 production and macrophagehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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macrophage recruitment in gastric epithelium.
Methods
Gastric cancer cell lines and tissue specimens
Human gastric cancer cells BGC-803, HGC-27 and MKN-
45 were cultured in RPMI 1640 supplemented with
10% fetal bovine serum, at 37°C in a humid incubator
with 5% CO2. 50 primary gastric cancer specimens with
matched adjacent non-malignant tissues were acquired
from patients under operation with all their informed
consent at Shengjing hospital, Chinese Medical University.
Haematoxylin- and eosin-staining sections were prepared
for assessment of the percentage of tumor cells. 36 speci-
mens with >80% tumor cells were selected for analysis, in
which 19 were Helicobacter pylori (H. pylori) positive. This
study was carried out with the approval of the ethical
committee of China Medical University. All experiments
were done at least three times.
Macrophage cell line RAW264.7
Macrophage RAW 264.7 was obtained from the Ameri-
can Type Culture Collection (Rockville, MD, USA), and
was cultured in Dulbecco’s modified Eagle’s medium,
supplemented with 10% fetal bovine serum, at 37°C in a
humid incubator with 5% CO2.
Real-time PCR
RNA was isolated from cells using TRIzol® LS Reagent
(Invitrogen Life Technologies) according to the manu-
facturer’s protocol. 1 μg RNA was reverse transcribed
into cDNA using Superscript III reverse transcriptase
(Invitrogen Life Technologies). Real-time PCR was carried
out in the LightCycler system (Roche Diagnostics) with
LightCycler DNA Master SYBR Green I Kit (Roche
Diagnostics). Gene expression was quantified by the com-
parative CT method, normalizing CT values to GAPDH
which was used as an internal control. Primer sequences
for Wnt5a were described in [8], for MCP-1 in [13], and
for IL-1β, interleukin 6 (IL-6), TNF-α and glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) in [18].
ELISA
Concentrations of MCP-1 and cytokines in cell (2 × 105)
culture supernatants were analyzed with Quantikine ELISA
kits (Boster, Wuhan, China) according to the manufac-
turer’s instructions.
Expression vector transfection
The pcDNA3.1 (Invitrogen, Paisley, United Kingdom)
Wnt5a expression vector was made by cloning of the
full-length PCR product of Wnt5a with PFU DNA poly-
merase (Invitrogen, Paisley, United Kingdom). Cells were
transfected with 2 μg pcDNA3.1-Wnt5a expression vectoror 2 μg pcDNA3.1 empty vector per well at 70% confluence
using Lipofectamine 2000 reagent (Invitrogen, Paisley,
United Kingdom) according to the manufacturer’s protocol.
RNA interference
Wnt5a siRNA vector and nonsilencing control siRNA
vector were acquired from Takala (Dalian, China). Cells
were seeded into a 24-well plate at a density of 2 × 105.
On the following day, cells were transfected with siRNA
vector using Lipofectamine 2000 (Invitrogen, United
Kingdom) according to the manufacturer’s instructions.
Macrophage chemotaxis assay
Transwell (COSTAR, 24-well, 8 μm pore) was used to
analyze macrophage chemotaxis. Macrophages (2 × 105)
were added to the upper chamber with the addition of
conditioned medium into the lower chamber, and then
incubated for 8 hours at 37°C and 5% CO2. Migrated
macrophages were fixed with 4% paraformaldehyde and
stained with crystal violet according to the manufacturer’s
protocol. The number of migrated macrophages in five
random microscopy fields was counted.
Cytoskeletal staining
Macrophages (2 × 105) were seeded on 24-well culture
plates, washed with PBS and fixed with 4% paraformalde-
hyde for 20 minutes. Then macrophages were incubated
with 0.2% Triton X-100 for 10 minutes. After blocking
with 1% bovine serum albumin, cells were incubated with
FITC-phalloidin (Sigma) for 40 minutes. Images were
captured by confocal fluorescent microscopy.
Statistical analysis
Mann-Whitney U-test was used to compare mRNA
expression between gastric cancer tissues and adjacent
non-malignant tissues, and between H.pylori-positive
and H. pylori-negative cancer tissues. Correlation among
Wnt5a, MCP-1 and IL-1β in gastric cancer tissues was
analyzed using Spearman’s rank correlation test. Differ-
ences among cells were analyzed by Student’s t-test or
one way ANOVA. SPSS version 11.0 (SPSS, Chicago, IL,
USA) was used to perform statistical analysis. A P-value
less than 0.05 was considered significant.
Results
Wnt5a mRNA was overexpressed in gastric cancer tissues
Real-time PCR was used to determine Wnt5a mRNA
level in 36 gastric cancer specimens and matched adjacent
non-malignant tissues. Wnt5a expression in each speci-
men was standardized to GAPDH expression. Compared
with matched non-malignant tissues, Wnt5a mRNA was
upregulated in 21 gastric cancer specimens, whereas
downregulated in 6 cases (Figure 1A). Wnt5a mRNA
level in cancer tissues was significantly higher than that
Figure 1 Wnt5a expression in gastric cancer tissues. (A) Wnt5a mRNA expression was upregulated in 21 gastric cancer specimens, whereas
downregulated in 6 cases by real-time PCR, compared with matched non-malignant tissues. *P < 0.01 vs Non-malignant tissues. (B) Wnt5a mRNA
level in cancer tissues was significantly higher than that in adjacent non-malignant tissues. *P < 0.01 vs Non-malignant. (C) Wnt5a mRNA level in
H. pylori-positive cancer tissues was higher than that in H. pylori-negative ones. *P < 0.05 vs H. pylori negative.
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Wnt5a mRNA level in H. pylori-positive cancer tissues was
higher than that in H. pylori-negative ones (Figure 1C).
Wnt5a stimulated MCP-1 expression in gastric cancer cells
To explore the role of Wnt5a overexpression in macro-
phage recruitment, we investigated the effect of Wnt5a
on the expression of MCP-1, a chemoattractant for mac-
rophages, in gastric cancer cell lines. After transfection
with Wnt5a expression vector (pcDNA3.1-Wnt5a) for
48 hours, BGC-803 cells expressed more MCP-1 mRNA
and secreted more MCP-1 protein into cell supernatant
(Figure 2A). To confirm the stimulatory effect of Wnt5a
on MCP-1 expression, we next transfected another
gastric cancer cell HGC-27 with pcDNA3.1-Wnt5a.
Similar to BGC-803 cells, Wnt5a-transfected HGC-27
cells overexpressed MCP-1 (Figure 2B). Furthermore,
we treated BGC-803 and HGC-27 cells with recombinant
Wnt5a (rWnt5a, 0.5 μg/ml, R&D system) for 8 hours.
Consistent with Wnt5a transfection, rWnt5a treatment
also increased MCP-1 expression (Figure 2C and 2D).
On the other side, we silenced Wnt5a expression in
Wnt5a-positive gastric cancer cell line MKN-45 [8] with
Wnt5a siRNA vector. As expected, MCP-1 expression was
downregulated (Figure 2E).Wnt5a induced IL-1β expression in gastric cancer cells
To elucidate the mechanisms underlying MCP-1 induc-
tion by Wnt5a, we investigated the expression of some
inflammatory cytokines which have been shown to be in-
volved in MCP-1 upregulation. In BGC-803 cells, Wnt5a
transfection led to a significant increase in IL-1β and TNF-
α expression (Figure 3A, 3B), but not in IL-6 (Figure 3C).
In addition, IL-1β expression was also upregulated in
Wnt5a-transfected HGC-27 cells (Figure 3D-3F). To the
contrary, IL-1β expression was downregulated in MKN-45
cells treated with Wnt5a siRNA vector (Figure 3G and
3H). Some other cytokines were further examined, includ-
ing interleukin 4 (IL-4), interleukin 8 (IL-8), interleukin 10
(IL-10), Prostaglandin E2 (PGE2) and interferon γ (IFN-γ).
ELISA detection showed that Wnt5a had no effect on the
expression of these cytokines in gastric cancer cells.
IL-1β mediated Wnt5a-induced MCP-1 upregulation in
gastric cancer cells
To determine whether IL-1β was involved in MCP-1
upregulation by Wnt5a, we treated Wnt5a-transfected
BGC-803 cells with recombinant IL-1 receptor antagonist
(rIL-1Ra, 0.5 μg/ml, Sigma) for 8 hours. It was found that
MCP-1 upregulation by Wnt5a transfection was signifi-
cantly inhibited (Figure 4A). Wnt5a-transfected HGC-27
Figure 2 Stimulation of MCP-1 expression by Wnt5a in gastric cancer cells. (A) and (B) Wnt5a transfection induced MCP-1 expression in
BGC-803 cells and HGC-27 cells by real-time PCR and ELISA. (C) and (D) Recombinant Wnt5a (0.5 μg/ml) treatment promoted MCP-1 expression
in BGC-803 cells and HGC-27 cells. (E) Wnt5a siRNA suppressed MCP-1 expression in MKN-45 cells. *P < 0.01 vs Control. Control V: control vector;
Wnt5a V: Wnt5a vector; rWnt5a: recombinant Wnt5a. Control si: control siRNA; Wnt5a si: Wnt5a siRNA. Data are expressed as mean ± SD, n = 3.
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the role of IL-1β in MCP-1 upregulation. As expected,
Wnt5a-induced MCP-1 overexpression in HGC-27 cells
was suppressed as well (Figure 4B). In addition, we used
recombinant IL-1β (rIL-1β, 1 μg/ml, Sigma) to treat BGC-
803 cells and HGC-27 cells, and found that MCP-1
expression was upregulated both in mRNA transcription
and protein secretion in these cells (Figure 4C and 4D).Wnt5a-conditioned medium promoted macrophage
chemotaxis
To evaluate whether the increased MCP-1 secretion was
functional, macrophage migration was assayed in vitro.
It was observed that the number of migrated macrophages
from transwell upper chamber increased significantly
when Wnt5a-conditioned medium from BGC-803 cells
transfected with Wnt5a expression vector was added to
the lower chamber (Figure 5). To clarify the role of
MCP-1 in the increased cell migration, we added MCP-
1 neutralizing antibody AF-479-NA (0.1 μg/ml, R&DSystems) into Wnt5a-conditioned medium. It was found
that the increased cell migration was inhibited remarkably
(Figure 5). Moreover, the enhanced macrophage migra-
tion by Wnt5a-conditioned medium was suppressed
when Wnt5a-transfected BGC-803 cells were pretreated
with rIL-1Ra (Figure 5).Wnt5a-conditioned medium induced macrophage
cytoskeletal changes
We next assessed the effect of Wnt5a-conditioned medium
from BGC-803 cells on macrophage cytoskeleton. The
cytoskeleton was stained using FITC-phalloidin (Sigma).
Consistent with migration assays, Wnt5a-conditioned med-
ium induced significant cytoskeletal changes, compared
with control medium (Figure 6). However, cytoskeletal
changes were inhibited by MCP-1 neutralizing antibody
AF-479-NA (0.1 μg/ml) (Figure 6). Furthermore, when
Wnt5a-transfected BGC-803 cells were pretreated with
rIL-1Ra, cytoskeletal changes induced by the conditioned
medium were also suppressed (Figure 6).
Figure 3 Induction of IL-1β expression by Wnt5a in gastric cancer cells. (A) and (B) Wnt5a transfection induced IL-1β and TNF-α expression
in BGC-803 cells by real-time PCR and ELISA. (C) Wnt5a transfection had no effect on IL-6 expression in BGC-803 cells. (D) Wnt5a transfection
stimulated IL-1β expression in HGC-27 cells. (E) and (F) Wnt5a transfection had no effect on TNF-α and IL-6 expression in HGC-27cells. (G) Wnt5a
siRNA inhibited IL-1β expression in MKN-45 cells. (H) Wnt5a siRNA has no effect on TNF-α expression in MKN-45 cells. *P < 0.01 vs Control. Control
V: control vector; Wnt5a V: Wnt5a vector. Control si: control siRNA; Wnt5a si: Wnt5a siRNA. Data are expressed as mean ± SD, n = 3.
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cancer tissues
Spearman’s rank correlation test was used to analyze the
correlation among Wnt5a, MCP-1 and IL-1β in gastric
cancer tissues. It was found that Wnt5a mRNA expression
was correlated with MCP-1 mRNA expression (Figure 7A)
and IL-1β mRNA expression (Figure 7B), respectively.
Moreover, MCP-1 mRNA expression was correlated with
IL-1β mRNA expression (Figure 7C).
Discussion
This study reveals that Wnt5a is overexpressed in gastric
cancer tissues in mRNA level, which is consistent withanother study showing Wnt5a overexpression in protein
level by immunohistochemistry [19], however, Wnt5a
overexpression has not been found in some gastric
cancer cell lines [20]. This discrepancy may be due to
the cancer-stromal interaction in gastric cancer micro-
environment. Actually, TNF-α was shown to induce
Wnt5a [21], and a nuclear factor-kappa B (NF-κB)
binding site was found in Wnt5a promoter [22], sug-
gesting H. pylori as an inducer of Wnt5a in gastric
epithelium. Recently, Wnt5a has been shown to be
induced by inflammatory stimuli in other cells, such
as macrophages [23,24] and bone marrow mesenchymal
cells (BMSC) [6].
Figure 4 Mediation of IL-1β in Wnt5a-induced MCP-1 upregulation in gastric cancer cells. (A) and (B) rIL-1Ra (0.5 μg/ml) inhibited MCP-1
upregulation by Wnt5a transfection in BGC-803 cells and HGC-27 cells. (C) and (D) rIL-1β (1 μg/ml) stimulated MCP-1 expression in BGC-803 cells
and HGC-27 cells. *P < 0.01 vs Wnt5a V; **P < 0.01 vs Control. Control V: control vector; Wnt5a V: Wnt5a vector; rIL-1Ra: recombinant IL-1 receptor
antagonist; rIL-1beta: recombinant IL-1β. Data are expressed as mean ± SD, n = 3.
Li et al. BMC Cancer 2014, 14:480 Page 6 of 9
http://www.biomedcentral.com/1471-2407/14/480Increasing evidence indicates Wnt5a as a pro-inflam-
matory mediator due to its involvement in some in-
flammatory processes and diseases, and its stimulatory
action on inflammatory cytokine production. Wnt5a was
upregulated in the Alzheimer’s disease mouse brain due
to β-amyloid peptide, inducing neuroinflammation and
neurotoxicity via inflammatory cytokines IL-1β and TNF-Figure 5 Promotion of macrophage chemotaxis by Wnt5a-conditione
BGC-803 cells enhanced macrophage migration by transwell analysis, whic
AF-479-NA (0.1 μg/ml) into the medium or the pretreatment of Wnt5a-tran
Wnt5a V. Control V: control vector; Wnt5a V: Wnt5a vector; rIL-1Ra: recombα [25]. Wnt5a was also involved in Human Immunodefi-
ciency Virus (HIV) associated neurological disorders by
promoting IL-1β, IL-6 and TNF-α production in the
spinal cord [26]. Moreover, Wnt5a overproduction in
rheumatoid arthritis was related to the secretion of
IL-1β and IL-6 in BMSC [6]. Consistent with the above
studies, the present study shows that Wnt5a stimulatesd medium. Wnt5a-conditioned medium from Wnt5a-transfected
h was inhibited by the addition of MCP-1 neutralizing antibody
sfected BGC-803 cells with rIL-1Ra. *P < 0.01 vs Control; **P < 0.01 vs
inant IL-1 receptor antagonist. Data are expressed as mean ± SD, n = 3.
Figure 6 Induction of macrophage cytoskeletal changes by Wnt5a-conditioned medium. Wnt5a-conditioned medium from Wnt5a-transfected
BGC-803 cells induced macrophage cytoskeletal changes by FITC-phalloidin and DAPI staining, which was inhibited by the addition of MCP-1 neutralizing
antibody AF-479-NA (0.1 μg/ml) into the medium or the pretreatment of Wnt5a-transfected BGC-803 cells with rIL-1Ra. Wnt5a V: Wnt5a vector; rIL-1Ra:
recombinant IL-1 receptor antagonist.
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http://www.biomedcentral.com/1471-2407/14/480gastric epithelial cells to produce IL-1β, suggesting the
involvement of Wnt5a in gastric inflammation.
Our results demonstrate that Wnt5a is an inducer of
MCP-1 in gastric cancer cells. First, Wnt5a expression
was correlated with MCP-1 expression in gastric cancer
tissues. Second, Wnt5a overexpression and exogenous
Wnt5a treatment elevated MCP-1 expression in gastric
cancer cells. Third, Wnt5a knockdown suppressed MCP-1Figure 7 Correlation among Wnt5a, MCP-1 and IL-1β in gastric cance
mRNA expression in gastric cancer tissues by Spearman’s rank correlation t
mRNA expression. P = 0.039. (C) MCP-1 mRNA expression was correlated wexpression. Moreover, Wnt5a-conditioned medium stimu-
lated macrophage chemotaxis and cytoskeletal changes,
which was blocked by MCP-1 neutralizing antibody AF-
479-NA. Taken together, our study suggests that Wnt5a
may be involved in macrophage recruitment in gastric
tissues via upregulating MCP-1.
The present study reveals a close link between MCP-
1 and IL-1β in gastric cancer. MCP-1 expression wasr tissues. (A) Wnt5a mRNA expression was correlated with MCP-1
est. P = 0.019. (B) Wnt5a mRNA expression was correlated with IL-1β
ith IL-1β mRNA expression, P = 0.011.
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http://www.biomedcentral.com/1471-2407/14/480correlated with IL-1β expression in gastric cancer tissues.
In gastric cancer cells, exogenous IL-1β stimulated MCP-
1 expression, whereas IL-1Ra had an inhibitory effect.
In addition, Wnt5a-induced macrophage chemotaxis
and cytoskeletal changes were inhibited by IL-1Ra, sug-
gesting IL-1β may mediate MCP-1 induction by Wnt5a.
This observation is consistent with some other studies
in which IL-1β stimulated MCP-1 expression in various
types of cells, such as alveolar type II epithelial cells
[14], peritoneal fibroblasts [15], endothelial cells [16]
and preadipocytes [17].
The infiltrated macrophages seem to play complicated
roles in the local tumor microenvironment upon interac-
tions between cancer cells and macrophages. It is well
known that these immunocytes can eradicate tumor cells,
acting as tumor inhibitors. However, macrophages in
tumor microenvironment may undergo alternative
activation and change into tumor promoters called
tumor associated macrophages (TAM). It has been
demonstrated that tumor cells can “educated” macro-
phages to escape immune surveillance on one hand,
and to create an environment fitful to growth on the
other. Therefore, the role of Wnt5a in gastric cancer
may be more complicated than we have known.
In summary, our study figures out a pathway that Wnt5a
stimulates gastric epithelial cells to produce IL-1β in an
autocrinal or paracrinal manner, and IL-1β induces gastric
epithelial cells to secret MCP-1, which chemoattracts more
macrophages into gastric mucosa. Moreover, this study has
shown that rIL-1Ra can suppress Wnt5a-induced MCP-1
upregulation and macrophage chemotaxis, suggesting
IL-1β blocking may be used to inhibit the aberrant
macrophage infiltration, and suppress the development
of chronic gastric inflammation and gastric cancer.Conclusions
Our results demonstrate that Wnt5a induces MCP-1
production in gastric cancer, which is mediated by IL-1β,
suggesting that Wnt5a is involved in macrophage recruit-
ment, and IL-1Ra may be used to inhibit macrophage
recruitment in gastric cancer.
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